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Items for this week’s EPI Update include: 
  
• Interim recommendations for the use of Haemophilus influenzae type 
b (Hib) conjugate vaccines.  
• Iowa State Poison Control Center annual report now available  
• Heparin pre-filled syringe contamination  
•        Wishing you happy holiday’s 
Interim Recommendations for the Use of Haemophilus influenzae Type b 
(Hib) Conjugate Vaccines. 
The Centers for Disease Control and Prevention (CDC), in consultation with the 
Advisory Committee on Immunization Practices (ACIP), the American Academy 
of Family Physicians, and the American Academy of Pediatrics, recommends 
that providers temporarily defer administering the routine Hib vaccine booster 
dose administered at age 12-15 months except to children in specific high risk 
groups.  
  
Children at increased risk for Hib disease include those with asplenia, sickle cell 
disease, human immunodeficiency virus infection and certain other 
immunodeficiency syndromes, and malignant neoplasms. American 
Indian/Alaska Native (AI/AN) children also are at increased risk for Hib disease, 
particularly in the first 6 months of life. CDC recommends that providers continue 
to vaccinate these children with available Hib conjugate vaccines according to 
the routinely recommended schedules, including the 12-15 month booster dose.  
If you have questions regarding these recommendations, please contact the Iowa 
Immunization Program at 1-800-831-6293. 
  
For more information, visit 
www.cdc.gov/mmwr/preview/mmwrhtml/mm56d1219a1.htm?s_cid=mm56d1219a
1_e. 
  
Iowa State Poison Control Center annual report now available  
The 2005-2006 Iowa State Poison Control Center (ISPCC) annual report is now 
available. Twenty-thousand Iowans were managed, resulting in a net savings to 
Iowa’s health care system of over $5 million! A study conducted in 2006, showed 
that every $1 invested in the ISPCC saved nearly $9 in medical expenses. The 
health benefits of the ISPCC include averting the use of outdated or harmful 
home remedies for poisonings. The ISPCC is able to decrease injury, illness, and 
death due to poisoning by assessing patients early, initiating decontamination, 
and identifying patients who need more aggressive management. 
For more information, visit www.iowapoison.org. 
  
Heparin pre-filled syringe contamination 
Physicians and Infection Control Practitioners are being alerted to watch for 
cases of Serratia bacteremias. Heparin flush pre-filled syringes from lot 
#070926H, manufactured by Sierra Pre-Filled Syringes have been linked to what 
is believed to be the source of the Serratia bacteremias contamination. The pre-
filled syringes were distributed to Colorado, Florida, Illinois, Pennsylvania and 
Texas. The manufacturer has issued a voluntary recall. If a cluster of Serratia 
bacteremia is suspected, the Serratia isolates should be sent to UHL (University 
Hygienic Laboratory) for further molecular sub typing.  
  
Happy holidays  
The Staff from the Center for Acute Disease Epidemiology would like to take this 
opportunity to wish you and yours a very safe and Happy Holiday Season. The 
next publication of the Friday Epi Update will be after the New Year. 
  
Remember, with the holidays quickly approaching there are no shortcuts 
when washing your hands! 
  
Have a healthy and happy week! 
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